Metomni-XL 50

Metomni-XL 50 by EMK Omni Pharma is a prescription-based Metoprolol Succinate ER Tablets IP formulation used for doctor-supervised blood pressure management, heart rate control and cardiovascular health support. Each uncoated extended release tablet contains Metoprolol Succinate IP 50 mg. Metomni-XL 50 belongs to the beta-blocker category of medicines and is commonly prescribed by healthcare professionals for patients who require support in managing hypertension, high blood pressure, elevated heart rate, cardiac workload and long-term heart health. Metomni-XL 50 Metoprolol Succinate Extended Release Tablets by EMK Omni Pharma are designed for physician-guided cardiac care where sustained release action, blood pressure control, heart rate regulation and cardiovascular risk management are required. This medicine should be used only as advised by a registered medical practitioner.

Metomni-XL 50 may be prescribed by doctors for patients who require support in managing high blood pressure, hypertension, elevated heart rate, cardiac strain and cardiovascular risk factors. It may be used as part of a complete physician-guided heart care plan for individuals who need blood pressure management, heart rate regulation and long-term cardiac health support. Metomni-XL 50 by EMK Omni Pharma is suitable for doctor-supervised treatment where sustained blood pressure control, cardiac workload reduction, heart rate management and cardiovascular support are required. Patients should not self-medicate, change the dosage, stop the medicine suddenly, chew or crush the tablet, or combine it with other medicines without consulting their doctor.